Medical Health & Life Science Research News

Report explores the 31.7% CAGR biosimilars market to reach US$ 23.63 billion by 2023 in 4 years

Medical Market Research

Report analyses biosimilars market by products, type of manufacturing, disease, and region. Apart from a comprehensive geographic product analysis and market sizing, report also provides a competitive landscape that covers growth strategies adopted by industry players over last three years. In addition, company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market.

- Advertising -

Get the Sample Papers of Biosimilars Market spread across 181 Pages, Profiling 10 Companies and Supported with 176 Tables and 37 Figures is now available at www.rnrmarketresearch.com/contacts…mple?rname=130963 .

The global biosimilars market is expected to reach USD 23.63 Billion by 2023 from USD 5.95 Billion in 2018, at a CAGR of 31.7%. Market growth is primarily driven by the increasing demand for biosimilar drugs due to their cost-effectiveness, increasing incidences of chronic diseases, and strategic collaborations resulting in enhanced productivity and clinical trial activities.

Premium Insights

1 Biosimilars Market Overview

2 Asia: Biosimilars Market, By Type of Product

3 Biosimilars Market, By Region

4 Geographical Snapshot: Biosimilars Market (Major Countries)

Competitive Landscape

1 Overview

2 Market Share Analysis, 2016

3 Competitive Scenario

4 Product Launches and Product Approvals

5 Partnerships, Collaborations, and Agreements

Biosimilars market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

- Advertising -

Click Here for More Information on Biosimilars Market with Forecast and Company Profiles at www.rnrmarketresearch.com/contacts…ying?rname=130963 .

Biosimilars market is segmented into in-house manufacturing and contract manufacturing. The contract manufacturing segment is expected to grow at the highest CAGR during the forecast period.

CMOs provide cost-saving benefits to companies in terms of facilities, equipment, and labor costs. “Asia is estimated to register the highest CAGR during the study period.”

Key Target Audience for this Report:

  • Biopharmaceutical drug manufacturers (biosimilars and biologics)
  • Private equity companies and venture capital firms
  • Healthcare service providers (hospitals and independent physicians)
  • Health insurance payers
  • Research and consulting service firms
  • Contract research organizations (CROs)
  • Contract manufacturing organizations (CMOs)
  • Pharmaceutical and medical associations

The key players in the biosimilars market include are Pfizer (US), Sandoz (Germany), Teva Pharmaceuticals (Israel), Amgen (US), Biocon (India), Dr. Reddy’s Laboratories (India), Celltrion (South Korea), and Samsung Biologics (South Korea).

Connect for More Details for More Information “Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing Type (In-house, Contract), Disease (Oncology, Autoimmune) - Global Forecast to 2023” report at www.rnrmarketresearch.com/contacts…hase?rname=130963 .

Biosimilars market was dominated by Europe in 2017. Europe is also expected to hold the largest share of the global market during the forecast period.

However, Asia is expected to witness the highest CAGR from 2018 to 2023.

A number of factors, such as the patent expiry of biologic products & the launch of new biosimilars, rising incidence of chronic disorders, and the emergence of new market participants are expected to propel market growth in the region.

Growth in the geriatric population and the subsequent increase in the incidence of age-related disorders and chronic disorders is also expected to increase the demand for biosimilars in Europe.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.